TY  - GEN
AU  - McArthur,G A
AU  - Maio,M
AU  - Arance,A
AU  - Nathan,P
AU  - Blank,C
AU  - Avril,M-F
AU  - Garbe,C
AU  - Hauschild,A
AU  - Schadendorf,D
AU  - Hamid,O
AU  - Fluck,M
AU  - Thebeau,M
AU  - Schachter,J
AU  - Kefford,R
AU  - Chamberlain,M
AU  - Makrutzki,M
AU  - Robson,S
AU  - Gonzalez,R
AU  - Margolin,K
TI  - Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study
SN  - 1569-8041
PY  - 2017///1221
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Indoles
KW  - administration & dosage
KW  - Male
KW  - Melanoma
KW  - Middle Aged
KW  - Mutation
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins B-raf
KW  - antagonists & inhibitors
KW  - Sulfonamides
KW  - Treatment Outcome
KW  - Vemurafenib
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1093/annonc/mdw641
ER  -